New lead­er­ship ap­pointed at Mcneil

The Ambler Gazette - - OBITUARIES - By Thomas Celona

John­son & John­son has ap­pointed new lead­er­ship to over­see McNeil Con­sumer Health­care, the com­pany’s trou­bled Fort Wash­ing­ton-based sub­sidiary that has is­sued a se­ries of re­calls over the past two years.

The phar­ma­ceu­ti­cal gi­ant an­nounced Sept. 13 San­dra E. Peter­son will join John­son & John­son as a group world­wide chair­man and a mem­ber of the com­pany’s ex­ec­u­tive com­mit­tee start­ing Dec. 1, ac­cord­ing to a press re­lease. Peter­son will have re­spon­si­bil­ity for the com­pany’s con­sumer group of com­pa­nies, in­clud­ing McNeil; in­for­ma­tion tech­nol­ogy; and global sup­ply chain.

Peter­son comes to John­son & John­son from Bayer, where she has served as chair­man and chief ex­ec­u­tive of­fi­cer of Bayer Crop- Sci­ence AG since 2010, ac­cord­ing to the re­lease. Prior to that, Peter­son held the posts of pres­i­dent and chief ex­ec­u­tive of­fi­cer of Bayer Med­i­cal Care and pres­i­dent of Bayer Health­Care AG’s Di­a­betes Care Division. Be­fore work­ing with Bayer, Peter­son worked in var­i­ous roles for Medco Health So­lu­tions, Nabisco Inc. and Whirlpool Corp.

“Sandi Peter­son is an ex­pe­ri­enced global leader known for her strate­gic think­ing and proven track record in grow­ing busi­nesses,” John­son & John­son’s new CEO Alex Gorsky said in the re­lease. “She brings 25 years of ex­pe­ri­ence to her new role, which will draw on her ex­per­tise in build­ing fully in­te­grated global busi­nesses and fo­cus­ing on growth.”

Peter­son will be based out of John­son & John­son’s New Brunswick, N.J., head­quar­ters, ac­cord­ing to the re­lease.

By over­see­ing the com­pany’s con­sumer com­pa­nies, Peter­son will be re­spon­si­ble for McNeil Con­sumer Health­care, which is head­quar­tered in the Fort Wash­ing­ton Of­fice Park with a plant on Camp Hill Road in the Fort Wash­ing­ton sec­tion of Whitemarsh Town­ship.

Since late 2009, McNeil has is­sued a string of more than 20 re­calls for med­i­ca­tion pro­duced at the Fort Wash­ing­ton plant, in­clud­ing the April 30, 2010, re­call of more than 136 mil­lion chil­dren’s and in­fants’ prod­ucts — the largest re­call of chil­dren’s medicine in his­tory.

McNeil halted pro­duc­tion at the plant fol­low­ing that re­call, and pro­duc­tion has yet to re­sume two and a half years later. John­son & John­son of­fi­cials have an­nounced plans to gut the fa­cil­ity and in­vest more than $100 in ren­o­va­tions, with the plant not expected to re­open un­til 2013.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.